Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Restructuring Costs (2020 - 2024)

Historic Restructuring Costs for Bioventus (BVS) over the last 5 years, with Q4 2024 value amounting to -$52000.0.

  • Bioventus' Restructuring Costs rose 2676.06% to -$52000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$52000.0, marking a year-over-year decrease of 10619.05%. This contributed to the annual value of -$52000.0 for FY2024, which is 10619.05% down from last year.
  • Per Bioventus' latest filing, its Restructuring Costs stood at -$52000.0 for Q4 2024, which was up 2676.06% from -$71000.0 recorded in Q4 2023.
  • In the past 5 years, Bioventus' Restructuring Costs ranged from a high of $4.6 million in Q4 2022 and a low of -$71000.0 during Q4 2023
  • In the last 5 years, Bioventus' Restructuring Costs had a median value of $576000.0 in 2022 and averaged $884750.0.
  • Its Restructuring Costs has fluctuated over the past 5 years, first skyrocketed by 57053.7% in 2022, then tumbled by 10452.17% in 2023.
  • Bioventus' Restructuring Costs (Quarter) stood at $563000.0 in 2020, then increased by 22.38% to $689000.0 in 2021, then skyrocketed by 570.54% to $4.6 million in 2022, then plummeted by 101.54% to -$71000.0 in 2023, then increased by 26.76% to -$52000.0 in 2024.
  • Its Restructuring Costs stands at -$52000.0 for Q4 2024, versus -$71000.0 for Q4 2023 and -$26000.0 for Q3 2023.